Structure-Based Discovery of Pyrimidine Aminobenzene Derivatives as Potent Oral Reversal Agents against P-gp- and BCRP-Mediated Multidrug Resistance
出版年份 2021 全文链接
标题
Structure-Based Discovery of Pyrimidine Aminobenzene Derivatives as Potent Oral Reversal Agents against P-gp- and BCRP-Mediated Multidrug Resistance
作者
关键词
-
出版物
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 9, Pages 6179-6197
出版商
American Chemical Society (ACS)
发表日期
2021-05-03
DOI
10.1021/acs.jmedchem.1c00246
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update
- (2020) Jinyun Dong et al. DRUG RESISTANCE UPDATES
- Short-chain fatty acids exert opposite effects on the expression and function of p-glycoprotein and breast cancer resistance protein in rat intestine
- (2020) Qiu-shi Xie et al. ACTA PHARMACOLOGICA SINICA
- One molecule two goals: A selective P-glycoprotein modulator increases drug transport across gastro-intestinal barrier and recovers doxorubicin toxicity in multidrug resistant cancer cells
- (2020) Marialessandra Contino et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structure-guided probing of the leukotriene C4 binding site in human multidrug resistance protein 1 (MRP1; ABCC1)
- (2019) Gwenaëlle Conseil et al. FASEB JOURNAL
- The multi-factorial nature of clinical multidrug resistance in cancer
- (2019) Yehuda G. Assaraf et al. DRUG RESISTANCE UPDATES
- PSMP/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic target
- (2019) Shaoping She et al. JOURNAL OF HEPATOLOGY
- Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR
- (2018) Imran Shair Mohammad et al. BIOMEDICINE & PHARMACOTHERAPY
- Redundant angiogenic signaling and tumor drug resistance
- (2018) Rajesh N. Gacche et al. DRUG RESISTANCE UPDATES
- Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation
- (2018) Youngjin Kim et al. SCIENCE
- Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents
- (2017) Giovanni Luca Beretta et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- 9-Deazapurines as Broad-Spectrum Inhibitors of the ABC Transport Proteins P-Glycoprotein, Multidrug Resistance-Associated Protein 1, and Breast Cancer Resistance Protein
- (2017) Katja Stefan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Toward a Better Understanding of the Complexity of Cancer Drug Resistance
- (2016) Michael M. Gottesman et al. Annual Review of Pharmacology and Toxicology
- ABC transporters as mediators of drug resistance and contributors to cancer cell biology
- (2016) Jamie I. Fletcher et al. DRUG RESISTANCE UPDATES
- ABCG2/BCRP: Specific and Nonspecific Modulators
- (2016) Diana Peña-Solórzano et al. MEDICINAL RESEARCH REVIEWS
- Patient-reported outcomes in the evaluation of toxicity of anticancer treatments
- (2016) Massimo Di Maio et al. Nature Reviews Clinical Oncology
- Design of inhibitors of BCRP/ABCG2
- (2015) Kapil Juvale et al. Future Medicinal Chemistry
- Determining the optimal dose in the development of anticancer agents
- (2014) Ron H. J. Mathijssen et al. Nature Reviews Clinical Oncology
- Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds
- (2012) A. Palmeira et al. CURRENT MEDICINAL CHEMISTRY
- Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance
- (2012) Suneet Shukla et al. DRUG RESISTANCE UPDATES
- Amine Linked Flavonoid Dimers as Modulators for P-Glycoprotein-Based Multidrug Resistance: Structure–Activity Relationship and Mechanism of Modulation
- (2012) Kin-Fai Chan et al. JOURNAL OF MEDICINAL CHEMISTRY
- ABC multidrug transporters: structure, function and role in chemoresistance
- (2007) Frances J Sharom PHARMACOGENOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now